The agricultural sciences company said Friday it will move production to lower-cost sources and away from certain high-cost active ingredient and formulation plants. The goal is to make FMC's ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

German semiconductor company Ferroelectric Memory (FMC) has raised €100 million ($116m) to support the development of its memory chips. Of the total raised, €77 million ($89m) resulted from the ...

FMC missed badly on its sales report last week. Half a dozen analysts downgraded the stock, and more price cuts are coming this week. FMC will lose money in 2025, but could be profitable again in 2026 ...

FMC missed badly on its sales report last week. Half a dozen analysts downgraded the stock, and more price cuts are coming this week. FMC will lose money in 2025, but could be profitable again in 2026 ...

FMC shares plummeted more than 40% this past week. Shares look cheap, but uncertainty is high. 10 stocks we like better than FMC › FMC (NYSE: FMC) stock is falling from the sky. After earnings were ...

FMC Corporation’s third-quarter earnings call revealed a mixed financial performance, with the company surpassing earnings per share (EPS) expectations but significantly missing revenue forecasts.

FMC Corporation (NYSE:FMC) shares are trending on Thursday. Check out the current price of FMC stock here. Shares of the Pennsylvanian company dropped 26.55% in after-hours trading on Wednesday to $21 ...

FMC beat on earnings but missed badly on sales last night. Revenue was cut in half due to reorganization moves preparatory to selling FMC's India business. FMC lowered its full-year forecast across ...

The company announced the signing of a new deal with a major peer in its industry. This should boost visibility and sales of a crucial fungicide it developed. FMC and Corteva have agreed to market ...

FMC Corp. (NYSE:FMC) -2.4% in Friday's trading, extending recent losses to its lowest in nearly nine years, as UBS downgrades shares to Neutral from Buy with a $38 price target, slashed from $66, ...